BDBM267509 4-(8-amino-3-(2,2-dimethyltetrahydro-2H-pyran-4-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(4-cyanopyridin-2-yl)benzamide::US9718828, Example, 38

SMILES CCc1cnc(NC(=O)c2ccc(cc2)-c2nc([C@H]3CC[C@@H](CC3)OC(C)=O)n3ccnc(N)c23)s1

InChI Key InChIKey=SYSKBXANQVWGNR-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 267509   

TargetTyrosine-protein kinase BTK(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267509(4-(8-amino-3-(2,2-dimethyltetrahydro-2H-pyran-4-yl...)
Affinity DataEC50:  55nMpH: 7.2 T: 2°CAssay Description:Btk enzyme activity is measured using the IMAP (immobilized metal ion affinity-based fluorescence polarization) assay as outlined below. Btk enzyme (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2018
Entry Details
Go to US Patent